Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Opsens Inc T.OPS

OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR... see more

Bullboard (TSX:OPS)

View:
Post by ivebeenthereon Nov 22, 2022 9:53am

Opsens parmi les 500 meilleures entreprises technologiques

La croissance exponentielle c'est maintenant que a se passe.Ils signent des contrats d'approvisionnement avec de nouveaux hopitaux de faon hebdomadaire. https://www.lesoleil.com/2020/11/18 ...more  
Comment by Pt6238on Nov 22, 2022 9:49am

RE:Q4 2022 revenues lower than Q3 2022

hopeless in short term! Expected to go south to 1.8
Post by retiredcfon Nov 22, 2022 9:27am

Globe & Mail

Aside from tax losses, it doesn't make much sense to sell at this price. They've completed the painful part and now we will hopefully reap the benefits once we get the full scale launch of ...more  
Post by bossuon Nov 22, 2022 9:19am

Q4 2022 revenues lower than Q3 2022

Just to say this will  be a long and painfull journey ! At on point Opsens had a17% Y2021 /Y2020 and  now ''zero'' growth ! Very disapointing FR  Hopefully OPS still ...more  
Post by retiredcfon Nov 22, 2022 9:01am

RBC

November 22, 2022 Opsens Inc. FQ4/22: Revenues marginally below RBC and consensus estimates in preparation for SavvyWire launch  ...more  
Post by bossuon Nov 21, 2022 3:31pm

Revenues Y/Y

Just some numbers for Year 2022                             Revenues    2019             ...more  
Comment by ddogoldon Nov 17, 2022 2:53pm

RE:RE:RE:$2,38

Agreed. I thought that with Health Canada and especially the FDA approvals we would be seeing some  news on orders . It's been only the sound of crickets . 
Comment by Possibleidiot01on Nov 17, 2022 12:59pm

RE:RE:$2,38

You shouldn't expect steady sustained stock rises here. IMO, the money comes in a rush eventually.
Comment by ddogoldon Nov 15, 2022 4:32pm

RE:$2,38

Another underwhelming day . Those PT's seem so far off / away . 
Comment by GoldenArmon Nov 11, 2022 3:42pm

RE:RE:Comparison

100% agree. A big bank has a lot invested in them.
Post by Redj4444on Nov 10, 2022 12:18pm

$2,38

Excellent temps d'acheter ce matin avant les resultats du quatrieme trimestre
Comment by WhiteknightAon Nov 06, 2022 7:12pm

RE:Comparison

Pink has enough capital to get them through their trial stage. That cash comes from a big investment social capital. The company will not go under at all. Their technology is far to valuable. They won ...more  
Comment by WhiteknightAon Nov 06, 2022 7:06pm

RE:Comparison

Both companies are excellent choices, and both companies will succeed. Pink is such a new company in its infancy stage right now. You can forget all the numbers related to their financials for the ...more